Ypsomed Holding AG Logo

Ypsomed Holding AG

Develops self-injection systems for pharma/biotech partners to simplify chronic disease therapy.

YPSN | SW

Overview

Corporate Details

ISIN(s):
CH0019396990
LEI:
391200QLIOTTBNPNSI14
Country:
Switzerland
Address:
Brunnmattstrasse 6, 3400 Burgdorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Ypsomed Holding AG is a leading developer and manufacturer of self-injection and infusion systems for self-medication. The company partners with pharmaceutical and biotech companies, providing a comprehensive portfolio of innovative platforms including injection pens, autoinjectors, and on-body devices. For over 40 years, Ypsomed has offered tailored self-care solutions designed to simplify therapy and improve quality of life for people with chronic conditions. Its platform ecosystem combines industrialized drug delivery technology with expert support services and integrated digital health solutions that support therapy management and clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ypsomed Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ypsomed Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-09-30 N/A Executive member Buy None 145,600.00 CHF
2024-09-26 N/A Executive member Sell None 129,352.00 CHF
2024-09-24 N/A Non-Executive member Buy None 42,776.00 CHF
2024-05-27 N/A Executive member Sell None 78,000.00 CHF
2024-05-22 N/A Executive member Sell None 154,000.00 CHF
2023-09-29 N/A Executive member Sell None 40,800.00 CHF
2022-06-23 N/A Non-Executive member Buy None 31,400.00 CHF
2022-06-23 N/A Executive member Buy None 11,760.00 CHF
2022-06-23 N/A Executive member Buy None 122.50 CHF
2022-06-14 N/A Non-Executive member Buy None 1,080,875.72 CHF

Peer Companies

Company Country Ticker View
BIODYNE CO., LTD. Logo
Develops automated liquid-based cytology systems and reagents for cancer diagnostics.
South Korea 314930
Biohit Oyj Logo
Develops diagnostic tests and lab systems for healthcare, research, and industrial laboratories.
Finland BIOBV
BIONEERCORPORATION Logo
Provides molecular biology tools & diagnostic kits for research and clinical applications.
South Korea 064550
BioNote, Inc. Logo
Manufactures veterinary diagnostics, analyzers, and software for animal health professionals.
South Korea 377740
Develops & manufactures HA-based biomaterials & medical devices for aesthetics & medical sectors.
South Korea 099430
Bioretec Oy Logo
Develops bioabsorbable orthopedic implants for adults & children, eliminating removal surgery.
Finland BRETEC
Boditech Med Inc. Logo
Develops & manufactures rapid point-of-care in-vitro diagnostic solutions for medical pros.
South Korea 206640
Bonesupport Holding Logo
Develops & markets injectable bioceramic bone grafts that remodel into bone to heal fractures.
Sweden BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium MLBON
Boule Diagnostics Logo
Global provider of complete hematology systems for human and veterinary diagnostics.
Sweden BOUL

Talk to a Data Expert

Have a question? We'll get back to you promptly.